James Brian Windsor - Dec 2, 2024 Form 4 Insider Report for Aileron Therapeutics, Inc. (ALRN)

Role
President and CEO
Signature
/s/ James Brian Windsor
Stock symbol
ALRN
Transactions as of
Dec 2, 2024
Transactions value $
$0
Form type
4
Date filed
12/4/2024, 04:05 PM
Previous filing
Mar 6, 2024
Next filing
Dec 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Stock Option (right to buy) Award $0 +518K $0.00 518K Dec 2, 2024 Common Stock 518K $2.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest as of 25% of the shares on December 2, 2025 and thereafter in equal monthly installments through December 2, 2028.